Immunomedics' $40M Deal Over Data Scandal Gets Initial OK
A New Jersey federal judge granted preliminary approval on Thursday to a $40 million settlement between pharmaceutical company Immunomedics Inc. and a class of its investors that will resolve claims that...To view the full article, register now.
Already a subscriber? Click here to view full article